Jason L Yu1,2, Yifan Liu1,3, Akshay Tangutur1, Monique Arnold1, Everett G Seay1, Alan R Schwartz1, Raj C Dedhia1,2. 1. Division of Sleep Surgery, Department of Otorhinolaryngology-Head and Neck Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. 2. Division of Sleep Medicine, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Philadelphia, Pennsylvania. 3. Department of Otolaryngology, Capital Medical University, Beijing, China.
Abstract
STUDY OBJECTIVES: Lower therapeutic positive airway pressure (PAP) levels are associated with improved response to non-PAP therapies in the treatment of obstructive sleep apnea. The aim of this study was to evaluate the prevailing notion that patients with apnea-predominant obstructive sleep apnea require higher therapeutic PAP levels compared to patients with hypopnea-predominant obstructive sleep apnea. METHODS: An institutional review board-approved retrospective review was performed using strict inclusion criteria: presence of type I or III sleep study, apnea-hypopnea index > 10 events/h, and adherence to auto-adjusting continuous positive airway pressure. Patients were stratified by apnea (> 50% apneas) or hypopnea (≤ 50% apneas) predominance, and PAP data were compared. Statistical analyses were performed using Student's t test and linear regression modeling. RESULTS: Between January 1, 2018 and January 1, 2020, 500 patients met inclusion criteria. Two hundred twenty-one (44.1%) patients were apnea-predominant and 279 (55.8%) were hypopnea-predominant. Apnea-predominant patients had a slightly greater mean PAP (9.01 vs 8.36, P = .002) than hypopnea-predominant patients. Univariable and multivariable linear regression of 7 variables (obstructive apnea percentage, age, sex, body mass index, apnea-hypopnea index, O2 nadir, mask type) showed obstructive apnea percentage was the weakest predictor of therapeutic PAP levels. CONCLUSIONS: Apnea-predominant individuals demonstrated a clinically insignificant difference in PAP level compared to hypopnea-predominant individuals; moreover, obstructive apnea percentage was not a strong predictor of therapeutic PAP levels. Of the modeled variables, the strongest predictor of PAP level was apnea-hypopnea index. Further studies are needed to explore these relationships as well as additional variables that may contribute to predicting therapeutic PAP levels. CITATION: Yu JL, Liu Y, Tangutur A, et al. Influence of apnea vs hypopnea predominance in predicting mean therapeutic positive airway pressures among patients with obstructive sleep apnea. J Clin Sleep Med. 2021;17(11):2171-2178.
STUDY OBJECTIVES: Lower therapeutic positive airway pressure (PAP) levels are associated with improved response to non-PAP therapies in the treatment of obstructive sleep apnea. The aim of this study was to evaluate the prevailing notion that patients with apnea-predominant obstructive sleep apnea require higher therapeutic PAP levels compared to patients with hypopnea-predominant obstructive sleep apnea. METHODS: An institutional review board-approved retrospective review was performed using strict inclusion criteria: presence of type I or III sleep study, apnea-hypopnea index > 10 events/h, and adherence to auto-adjusting continuous positive airway pressure. Patients were stratified by apnea (> 50% apneas) or hypopnea (≤ 50% apneas) predominance, and PAP data were compared. Statistical analyses were performed using Student's t test and linear regression modeling. RESULTS: Between January 1, 2018 and January 1, 2020, 500 patients met inclusion criteria. Two hundred twenty-one (44.1%) patients were apnea-predominant and 279 (55.8%) were hypopnea-predominant. Apnea-predominant patients had a slightly greater mean PAP (9.01 vs 8.36, P = .002) than hypopnea-predominant patients. Univariable and multivariable linear regression of 7 variables (obstructive apnea percentage, age, sex, body mass index, apnea-hypopnea index, O2 nadir, mask type) showed obstructive apnea percentage was the weakest predictor of therapeutic PAP levels. CONCLUSIONS: Apnea-predominant individuals demonstrated a clinically insignificant difference in PAP level compared to hypopnea-predominant individuals; moreover, obstructive apnea percentage was not a strong predictor of therapeutic PAP levels. Of the modeled variables, the strongest predictor of PAP level was apnea-hypopnea index. Further studies are needed to explore these relationships as well as additional variables that may contribute to predicting therapeutic PAP levels. CITATION: Yu JL, Liu Y, Tangutur A, et al. Influence of apnea vs hypopnea predominance in predicting mean therapeutic positive airway pressures among patients with obstructive sleep apnea. J Clin Sleep Med. 2021;17(11):2171-2178.
Authors: Kate Sutherland; Craig L Phillips; Amanda Davies; Vasanth K Srinivasan; Oyku Dalci; Brendon J Yee; M Ali Darendeliler; Ronald R Grunstein; Peter A Cistulli Journal: J Clin Sleep Med Date: 2014-09-15 Impact factor: 4.062
Authors: Clara H Lee; Everett G Seay; Benjamin K Walters; Nicholas J Scalzitti; Raj C Dedhia Journal: J Clin Sleep Med Date: 2019-08-15 Impact factor: 4.062
Authors: Shane A Landry; Simon A Joosten; Danny J Eckert; Amy S Jordan; Scott A Sands; David P White; Atul Malhotra; Andrew Wellman; Garun S Hamilton; Bradley A Edwards Journal: Sleep Date: 2017-06-01 Impact factor: 5.849
Authors: Soroush Zaghi; Jon-Erik C Holty; Victor Certal; Jose Abdullatif; Christian Guilleminault; Nelson B Powell; Robert W Riley; Macario Camacho Journal: JAMA Otolaryngol Head Neck Surg Date: 2016-01 Impact factor: 6.223
Authors: Erica Thaler; Richard Schwab; Joachim Maurer; Ryan Soose; Christopher Larsen; Suzanne Stevens; Damien Stevens; Maurits Boon; Colin Huntley; Karl Doghramji; Tina Waters; Alan Kominsky; Armin Steffen; Eric Kezirian; Benedikt Hofauer; Ulrich Sommer; Kirk Withrow; Kingman Strohl; Clemens Heiser Journal: Laryngoscope Date: 2019-09-14 Impact factor: 3.325